The post Jade reports interim Phase I results of JADE101 for IgAN appeared first on Hospital Management.
Jade reports interim Phase I results of JADE101 for IgAN
Jade Biosciences has reported positive interim data from its Phase I trial studying JADE101, an investigational anti-APRIL monoclonal antibody for IgAN. The post Jade reports interim Phase I results of JADE101 for IgAN appeared first on Hospital Management.
728×90 ad placeholder
Jade Biosciences has reported positive interim data from its Phase I trial studying JADE101, an investigational anti-APRIL monoclonal antibody for IgAN.
View original source →